Trial Profile
Randomized trial for prevention of post ERCP pancreatitis with celecox tablets
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- 28 Jan 2017 Status changed from recruiting to completed.
- 05 Mar 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
- 05 Mar 2014 New trial record